Ivermectin, a widely known antiparasitic drug, has gained significant attention for its potential off-label applications in treating various non-parasitic conditions, including cancer, inflammation, and skin diseases. Research has been growing on its role in oncology, particularly in combination with other drugs like fenbendazole, and its ability to inhibit molecular targets in tumor models. Additionally, recent regulatory changes and legal developments have impacted its availability for off-label use.
Ivermectin’s Anti-Tumor Effects & Combination Therapy: Emerging research suggests that ivermectin has anti-tumor properties, particularly through its ability to modulate cell signaling pathways, inhibit key proteins involved in cancer progression, and induce apoptosis (programmed cell death).
Mechanisms of Action in Cancer Treatment
- HSP27 Inhibition in Prostate Cancer
A recent NIH study demonstrated that ivermectin inhibits Heat Shock Protein 27 (HSP27) in castration-resistant prostate cancer (CRPC) models. HSP27 is known to play a role in cancer cell survival and resistance to therapy. By inhibiting this protein, ivermectin was found to enhance the efficacy of oncogene-targeted therapies, potentially making it a valuable adjunct in cancer treatment. - WNT/β-catenin Pathway Modulation
Ivermectin has been shown to target the WNT/β-catenin signaling pathway, which is frequently activated in aggressive cancers such as colorectal, breast, and lung cancer. Inhibiting this pathway can suppress tumor growth and metastasis. - Enhancing Chemotherapy Efficacy
When used in combination with chemotherapy or other repurposed drugs like fenbendazole, ivermectin has demonstrated synergistic effects in cancer models. Fenbendazole, an anthelmintic like ivermectin, also exhibits anti-tumor properties by disrupting microtubule formation and glucose metabolism in cancer cells. The combination of these two drugs may enhance tumor suppression, especially in drug-resistant cancers.
Ivermectin in Skin Diseases: Ivermectin has been successfully used to treat various dermatological conditions, including:
- Rosacea: An FDA-approved topical formulation of ivermectin (Soolantra) is used to treat inflammatory lesions of rosacea.
- Scabies & Demodex Infestations: Ivermectin has been effective in clearing resistant cases of scabies and mite-related skin diseases.
- Psoriasis & Other Inflammatory Skin Disorders: There is some evidence suggesting that ivermectin may have anti-inflammatory benefits in conditions like psoriasis, though further studies are needed.
Potential Role in Inflammation & Autoimmune Disorders: Due to its ability to modulate the immune system, ivermectin is being investigated for chronic inflammatory diseases, including:
- Rheumatoid Arthritis
- Multiple Sclerosis
- Inflammatory Bowel Disease (IBD)
Its immunomodulatory properties suggest a broader role in controlling excessive immune responses.
Regulatory Changes: Off-Label Prescribing of Ivermectin: As of June 1, 2023, restrictions on prescribing oral ivermectin for off-label uses have been lifted, allowing general practitioners (GPs) and other non-specialist physicians to prescribe it for various conditions beyond parasitic infections. Previously, prescribing was limited to specialists in dermatology, infectious diseases, and gastroenterology.
This change means patients can more easily obtain ivermectin for conditions where research suggests potential benefits, such as cancer, inflammation, and dermatological diseases.
FDA Lawsuit Settlement Over Ivermectin Guidance: In a recent legal case, the FDA settled a lawsuit brought by doctors who claimed that the agency’s stance against ivermectin harmed their medical practice. The lawsuit focused on the FDA’s social media posts and public statements that discouraged ivermectin’s use for COVID-19, which some doctors argued interfered with doctor-patient decision-making. The case emphasized the fine line between regulatory oversight and medical freedom, ultimately leading to clarifications on off-label prescribing rights.
Conclusion: Ivermectin continues to be an intriguing drug with potential beyond its traditional antiparasitic role. Its anti-tumor effects, particularly in combination with other repurposed drugs like fenbendazole, show promise in cancer research. It has also been used for skin conditions and inflammation. Recent regulatory changes and legal cases have further shaped its accessibility, making it easier for physicians to prescribe it off-label. While more clinical trials are needed, ivermectin’s potential role in medicine remains a topic of active investigation.
At Towne Lake Family Pharmacy, we compound Ivermectin into higher strengths than the traditional 3mg strengths sold by the chain and large pharmacies. Making it convenient and more cost effective to take just 1 higher mg capsule as opposed to taking multiple 3mg tablets.